Breast Cancer Perspective

 
 
  • Preventing Cardiac Dysfunction During Breast Cancer Therapy   Dr John Mandrola sits down with Dr Geeta Gulati and Dr Torbjorn Omland to discuss the late-breaking PRADA trial from the American Heart Association sessions.
  • Quiz: The Alcohol-Cancer Connection How much do you know about the link between alcohol and cancer and how this influences advice to patients?
  • Alcohol and Cancer: Drink at Your Own Risk Alcohol consumption has been causally linked to nine cancers, including female breast cancer, and recent evidence has begun to clarify the factors that affect an individual's risk.
  • What Is Optimal Endocrine Therapy in Early Breast Cancer? Dr Vivianne Tjan-Heijnen reviews evidence from TEXT, SOFT, and ATLAS to identify optimal hormonal strategies for young women with early breast cancer, as presented at an ECC educational session.
  • Systemic Options for Treating Brain Metastases The therapeutic challenge of brain metastases in lung cancer, breast cancer, and melanoma is being met by a growing number of systemic therapies, as highlighted in an integrated session of ECC 2015.
  • Breast Cancer Screening: The Evidence is Piling Up   The American Cancer Society is now joining USPSTF is questioning the need for routine screening mammography. This article provides a family medicine perspective.
  • Highlights From ECC: Breast Cancer Dr Giuseppe Curigliano provides highlights from breast cancer research presented at the 2015 European Cancer Congress.
  • Breast Cancer Mortality After Diagnosis of DCIS   Dr Andrew Kaunitz comments on the bottom-line messages of this important study.
  • Tamoxifen or AI: Breast Cancer Subtypes Narrow Choice In early breast cancer, the biologic subtype provides a clue to the optimal choice of adjuvant endocrine therapy, as indicated by data from BIG 1-98 and discussed by Dr Lidia Schapira.
  • Should Women Have Fewer Mammograms? What's Right? Testing patients for life-altering diseases like cancer has saved many lives, no doubt. But do the costs of screening outweigh the benefits? For some conditions, many experts are starting to say yes.
  • Breast Cancer Symposium (BCS) 2015 Read clinically focused news coverage of key developments from BCS 2015.
  • Heart Disease: What's Bad for the Goose Is Bad for the Gander   Dr Black interviews Dr Martha Gulati on why clinicians need to consider cardiovascular disease in their female patients, and the similarities and differences in CVD between men and women.
  • Overdiagnosis of Breast Cancer Is Clinically Insignificant Dr Feig does not believe that breast cancer screening has resulted in significant overdiagnosis and unnecessary treatment of women, and is critical of studies suggesting that there is a problem.
  • Overdiagnosis of Breast Cancer Is Real Dr Bleyer coauthored a study suggesting that breast cancer is overdiagnosed by 31%. In this interview, he addresses the criticisms and how unprepared he was for the backlash on this 'third rail' topic.
  • Radiology's Overdiagnosis Problem Dr Saurabh Jha guest-edited an issue of Academic Radiology devoted to the topic of overdiagnosis. Medscape asks him why radiologists should be concerned about this topic.
  • Has Choosing Wisely Affected Clinical Practice? The Choosing Wisely campaign, which discourages unnecessary medical tests and procedures, has been lauded as a step in the right direction, but has it affected oncologists' patient care?
  • Overcoming Resistance to Targeted Therapies As the 2015 ASCO annual meeting, experts in targeted therapies described the problem of drug resistance and efforts to overcome resistance.
  • ASCO Takeaways for Primary Care Physicians The most important clinical pearls for primary care physicians from the year's biggest cancer meeting.
  • Oncologist Asks for Your Second Opinion   Dr Kathy Miller asks what you would do in a second-opinion workup to determine whether a breast cancer patient needs a change in management, and to compare it with the workup she actually received.
  • Breast Cancer Screening: Family Medicine Perspectives   Drs Charles Vega and Gabriel A. Rivera discuss the role of PCPs in breast cancer screening and the controversy behind false-positive results.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.